Background: Maternal obesity is increasingly prevalent in many westernized
Discussion: Higher maternal BMI is associated with increased risk of wheeze, cough, and maternally reported lower respiratory tract infection in infancy. These associations were independent of maternally reported paternal BMI. These observations might be explained by intrauterine effects of maternal obesity upon respiratory or immune development.
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| INTRODUCTION
Maternal obesity is increasingly prevalent in westernized countries, including the United Kingdom, where over half of women of childbearing age are either overweight or obese. 1 Obesity amongst pregnant women has significantly increased over time, with first trimester obesity more than doubling from 7.6% during the late 1980s to 15.6% two decades later. 2 There have been multiple reports of increased risk of wheeze, [3] [4] [5] [6] [7] and some of asthma, [8] [9] [10] in children born to obese mothers. Some studies suggest higher rates of gestational weight gain might also be associated with greater childhood wheeze risk. 11, 12 Together these findings suggest maternal body composition during pregnancy might affect respiratory or immune development, or both. Adverse effects upon the developing immune system or upon infant lung structure and function might arise in utero due to inflammatory, metabolic, or immunological consequences of maternal obesity. 13 Alternatively, postnatal socioeconomic and lifestyle factors shared within families might confound the relationship between maternal obesity and childhood wheeze.
We previously found greater maternal fat mass and body mass index (BMI) were associated with increased risk of the transient wheeze phenotype but not with atopy, wheeze, or asthma at age 6 years. 5 The transient wheeze phenotype is associated with reduced lung function in early life and an increased risk of wheeze with respiratory infections during the preschool years. 14 The relative strength of the association with this phenotype suggests maternal obesity might be linked to childhood wheeze through adverse effects upon respiratory or immune development, leading to reduced lung function, increased susceptibility to infection, or both. An association between maternal pre-pregnancy obesity and reduced infant lung function has been reported using data from the Wheezing Illnesses Study Leidsche Rijn (WHISTLER). 7 Whether maternal obesity is also associated with increased susceptibility to infections from early infancy is less clear, however. 10 It is not known whether maternal obesity is associated specifically with wheeze or also with other respiratory symptoms. Moreover, it is not clear whether maternal obesity is associated with increased infections in general or specifically with respiratory infections.
This study examined the relationship between maternal prepregnancy obesity and illnesses during infancy, in particular maternal reports of symptoms and diagnoses associated with respiratory infections. The relationship between pregnancy weight gain and these outcomes was also examined. Shared familial variables might confound the associations found between maternal obesity and childhood respiratory outcomes. Potentially important familial factors include diet, physical activity, or heritable propensity to obesity. Since factors associated with obesity in mothers might also be associated with obesity in fathers paternal BMI was considered a suitable proxy for unmeasured confounders influencing the relationship between maternal body composition and the risk of wheeze, cough and maternally reported infections during infancy.
| MATERIALS AND METHODS

| Participants
Participants were mothers, and children from the Southampton Women's Survey cohort. 15 The survey recruited women aged 20-34 years during 1998-2002 when they were not pregnant. At recruitment, participating women were interviewed and anthropometric measurements were made, including height and weight. Women who subsequently became pregnant were interviewed at 11 and 34 weeks of pregnancy and childhood follow-up visits were scheduled at 6 and 12 months. Twins were excluded from the analysis and only the first child born to each woman after recruitment was followed within the study. Of 3158 live births, 2823 (89%) were seen at both 6 and 12 months of age ( Figure 1 ). Maternal weights and heights were recorded for 2799 (99%) of the women whose children had complete follow-up. These mother-child pairs formed the analytic sample. were measured at birth and 6 months using Holtain skinfold calipers (Holtain Ltd., Dyfed, UK). Subscapular adiposity change conditional upon initial measurements was calculated using regression to account for exact age and for regression to the mean.
| Childhood illnesses and respiratory symptoms
At the 6 and 12 month follow-up visits mothers were asked whether their child had suffered from either of the following symptoms since the last visit: "one or more episodes of chest wheezing/whistling" or "waking at night coughing for three or more nights in a row" (prolonged cough). Mothers were also asked if their child had suffered from "one or more episodes of croup or a croupy cough," "bouts of vomiting or diarrhea lasting 2 days or longer," or "a doctor-diagnosed chest infection," 'bronchitis," "bronchiolitis," "pneumonia," or "ear infection."
Chest infection, bronchitis, bronchiolitis, and pneumonia were combined into one lower respiratory tract infection (LRTI) variable.
Binary variables were created by combining responses to the 6 and 12 month questionnaires to indicate whether the child had suffered from each outcome during the first year of life.
| Statistical methods
Relative risks for binary outcomes were modeled using Poisson regression with robust variance, this being an appropriate method for analyzing common outcomes where odds ratios cannot be interpreted as relative risks. 16 Our primary aim was to assess the overall impact of maternal obesity. However, to assess the direct effect of maternal BMI we considered a further model adjusting for potential postnatal mediators of the effects of maternal obesity. In this model we adjusted for birthweight and adiposity gain in early infancy in addition to the adjustment set identified by the DAG and paternal BMI. Finally, we excluded children born at less than 35 weeks' gestation in a sensitivity analysis to address the possibility of effect modification by gestation.
Bonferroni correction was considered over-conservative since the analyses were designed a priori to test a limited number of hypotheses and not all the tests were independent. 19 We focused our interest on results with P-values ≤ 0.01 and considered consistency of the findings in our interpretation. Stata® 12 (Stata Corp., College Station, TX) was used for all analyses.
3 | RESULTS
| Participants
Of the 3158 mother-child pairs in the Southampton Women's Survey cohort, 2799 had both maternal BMI and infant 6 and 12 month followup data. These 2799 mother-child pairs were included in the analytic sample. Participant mothers had comparable BMIs to those not included within the analytic sample. Compared with non-included | 1293 mothers, those included were of higher educational attainment, less likely to smoke in pregnancy and more likely to have a history of asthma; included infants were of greater birthweight than those not included in the analytic sample ( (Table 3) . Maternal overweight and maternal obesity were positively associated with prolonged cough, but failed to meet significance (P ≤ 0.01). There was an isolated association between maternal overweight but not obesity and diarrhea or vomiting. The direction of these effects persisted after including maternally reported paternal BMI in the model (Table 4) .
| Relationship between maternal weight gain in pregnancy and infant symptoms and infections
No associations were found between maternal weight gain in pregnancy and risk of symptoms or infections during infancy in either the full cohort (Table 4) or after excluding children born before 35
weeks' gestation (data not shown). Neither inadequate nor excessive weight gain was associated with risk significantly different from that of infants born to mothers with adequate weight gain.
| Contribution of postnatal mediators
Significant positive associations were found between maternal BMI and infant wheeze, persistent cough and LRTI in an alternative model which adjusted for postnatal factors potentially mediating the effects of maternal obesity. After adjusting for the DAG-identified confounders, paternal BMI, child's birthweight and adiposity gain during infancy the relative risks for wheeze, cough and LRTI were, respectively, 1.09 (1.05-1.14), 1.11 (1.05-1.18), and 1.11 (1.04-1.18).
| DISCUSSION
This study found greater maternal pre-pregnancy BMI to be associated with increased risk of maternally reported wheeze, cough, and LRTI in the first year of life. These associations persisted after adjustment for maternal age, education, parity, and smoking in pregnancy, and also after adjustment for maternally reported paternal BMI as a proxy for unmeasured shared familial confounding. The associations found between maternal BMI and maternally reported infections were minimally diminished by inclusion of potential postnatal mediators and are consistent with maternal obesity acting in utero to adversely affect respiratory or immune development, or both.
Guidelines from both the National Institute for Health and Care
Excellence and the Royal College of Obstetricians and Gynaecologists recommend that women who are obese should be encouraged to lose weight before becoming pregnant in order to benefit their own health and that of their child. 20, 21 This study extends the findings of previous studies reporting increased childhood wheeze risk in association with greater maternal BMI and provides further support for these recommendations. Of the many studies which have found associations between higher maternal BMI and increased childhood wheeze, most reported wheeze during infancy, 3, 22 or during the preschool years, 4, 6, 23 periods when wheezing is frequently triggered by respiratory infections and may not persist. A smaller number of studies reported associations between maternal obesity and wheeze at school age, 9, 12 or during adolescence, 8 when wheezing is more likely to be a feature of asthma. The mechanisms underlying these associations are unclear, although notably our previous study did not support an association between maternal obesity and atopy. 5 Few studies have considered the relationship between maternal obesity and symptoms other than wheeze or investigated respiratory infections as an outcome. An obesogenic maternal diet, that is one high in carbohydrates but low in fruits and vegetables, has been linked with increased risk of life-threatening respiratory syncytial virus infection. 24 Moreover, a registry study has shown that maternal pre-pregnancy obesity is associated with a higher rate of admission for any respiratory diagnosis between birth and five years of age. 25 Although respiratory infections are a common cause of admission in this age range, the outcome was not restricted to infections and included non-infectious outcomes, including asthma, and diagnoses, such as hypoxemia and need for mechanical ventilation, which might arise as a consequence of significant illness of non-respiratory origin. The MoBa prospective cohort has, however, considered the risk of respiratory tract infection separately from that of wheeze, or other respiratory symptoms or diagnoses . Mothers in the MoBa study were asked to recall episodes of respiratory syncytial-virus, bronchiolitis, bronchitis, or pneumonia between birth and 6 months and between 6 and 18 months. In contrast to our findings, although maternal obesity was related to maternally reported LRTI in crude analyses, this association did not remain after adjusting for lifestyle and socioeconomic characteristics. 3 Differences in outcome reporting and classification, particularly with respect to age of assessment, might underlie the differences between this study and the MoBa study results. Moreover maternal anthropometry was reported rather than measured in the MoBa study which might have led to inaccuracy and weakening of any association.
There is mounting evidence to suggest that obese individuals are at increased risk of respiratory infection. During the 2009 H1N1 influenza pandemic, obese individuals were found to be more susceptible and to suffer more severe outcomes than those of normal weight. 26 Data linkage 27 and prospective cohort studies 28 have shown obese adults to be at increased risk of community-acquired pneumonia and there is also evidence that childhood obesity is associated with increased respiratory infections. 29 Mechanisms proposed to explain these associations include mechanical effects of obesity, including increased risk of gastro-oesophageal reflux and aspiration, and effects of inflammatory mediators produced by adipose tissue. 30 Inflammatory mechanisms might also mediate intergenerational effects of an obesogenic diet or of maternal obesity upon offspring development and later health. Alternatively, epigenetic effects, or changes to maternal or infant microbiomes might be responsible for the developmental consequences of maternal diet and body composition. 31, 32 In utero exposure to inflammatory states, such as chorioamnionitis and smoking, has been associated with both infant respiratory illness and childhood asthma. 33, 34 Inflammatory mechanisms might also underlie the associations with maternal obesity since obese pregnant women have higher levels of proinflammatory cytokines in their serum and amniotic fluid than pregnant women of normal weight. 35, 36 The
Tucson Infant Immune Study reported that children of mothers in the highest third of pregnancy weight gain were at increased risk of developing asthma and had persistently elevated TNF-α in early life, 11 suggesting prenatal influences might, indeed, affect fetal immune development.
An alternative explanation for the associations we found could be that maternal obesity adversely affects lower airway development.
Alterations in airway branching, compliance or caliber might reduces its value as a proxy for unmeasured confounders.
In conclusion, we found that greater maternal BMI is associated with increased risk of cough, wheeze and lower respiratory tract infection in infancy. These associations remained after including paternal BMI in the model and the postnatal mediators birthweight and infant adiposity gain. While these associations might still reflect unmeasured confounders, intrauterine effects of maternal obesity upon immune or respiratory development might also explain these observations. Any other restrictions to these data: There are no further restrictions applicable to these data.
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